23rd January 2025, Kathmandu
Om Mega Shree Pharmaceuticals Limited will launch its initial public offering (IPO) on February 3, 2025 (Magh 21, 2081). In the first phase, the company seeks investments from Nepalis working abroad. This initiative encourages the diaspora to invest in Nepal’s growing pharmaceutical industry.
Om Mega Shree IPO 2025
IPO Details
The company plans to issue 1.8 million shares at a face value of NPR 100 per share, amounting to NPR 180 million. This represents 30% of its authorized capital, which totals NPR 600 million. The IPO offers shares in multiple phases to accommodate various investor categories.
Share Allocation
The company has divided the shares as follows:
10% (180,000 shares) for Nepali citizens employed abroad.
5% (90,000 shares) for collective investment funds.
3% (54,000 shares) for company employees.
1.476 million shares for the general public in the second phase.
This allocation strategy creates opportunities for diverse participation in the investment process.
Application Process
Nepalis with valid labor permits who are working overseas can apply for shares from February 3 to February 17, 2025 (Magh 21 to Falgun 5, 2081). Applications can be submitted through ASBA-approved banks and financial institutions or the Mero Share online platform. Investors must apply for at least 10 shares, with a maximum limit of 10,000 shares.
The application process is designed to be simple and accessible for all eligible participants.
Prabhu Capital to Manage the IPO
Prabhu Capital Limited will handle the IPO’s issuance and sales management. The company has already obtained approval from the Securities Board of Nepal (SEBON), ensuring a streamlined process for the offering. Encouraging Diaspora Investment
Om Mega Shree Pharmaceuticals aims to involve Nepalis abroad in the company’s growth. This IPO allows the diaspora to invest directly in Nepal’s pharmaceutical sector, fostering economic ties and mutual benefits.
The initiative highlights the company’s focus on inclusive growth and provides Nepalis working abroad with a meaningful way to support and profit from the country’s expanding industries.
